Autophagy as a therapeutic target in cardiovascular disease

Andriy Nemchenko, Mario Chiong, Aslan T Turer, Sergio Lavandero, Joseph A Hill

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

The epidemic of heart failure continues apace, and development of novel therapies with clinical efficacy has lagged. Now, important insights into the molecular circuitry of cardiovascular autophagy have raised the prospect that this cellular pathway of protein quality control may be a target of clinical relevance. Whereas basal levels of autophagy are required for cell survival, excessive levels - or perhaps distinct forms of autophagic flux - contribute to disease pathogenesis. Our challenge will be to distinguish mechanisms that drive adaptive versus maladaptive autophagy and to manipulate those pathways for therapeutic gain. Recent evidence suggests this may be possible. Here, we review the fundamental biology of autophagy and its role in a variety of forms of cardiovascular disease. We discuss ways in which this evolutionarily conserved catabolic mechanism can be manipulated, discuss studies presently underway in heart disease, and provide our perspective on where this exciting field may lead in the future. This article is part of a special issue entitled "Key Signaling Molecules in Hypertrophy and Heart Failure."

Original languageEnglish (US)
Pages (from-to)584-593
Number of pages10
JournalJournal of Molecular and Cellular Cardiology
Volume51
Issue number4
DOIs
StatePublished - Oct 2011

Fingerprint

Autophagy
Cardiovascular Diseases
Heart Failure
Therapeutics
Quality Control
Hypertrophy
Heart Diseases
Cell Survival
Proteins

Keywords

  • AMPK
  • Autophagy
  • Cardiac hypertrophy
  • HDAC inhibitors
  • Heart failure
  • Hypertrophy
  • IP3
  • MTOR
  • P53
  • PKA
  • Plasticity
  • Remodeling

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Autophagy as a therapeutic target in cardiovascular disease. / Nemchenko, Andriy; Chiong, Mario; Turer, Aslan T; Lavandero, Sergio; Hill, Joseph A.

In: Journal of Molecular and Cellular Cardiology, Vol. 51, No. 4, 10.2011, p. 584-593.

Research output: Contribution to journalArticle

Nemchenko, Andriy ; Chiong, Mario ; Turer, Aslan T ; Lavandero, Sergio ; Hill, Joseph A. / Autophagy as a therapeutic target in cardiovascular disease. In: Journal of Molecular and Cellular Cardiology. 2011 ; Vol. 51, No. 4. pp. 584-593.
@article{25fd192697ec46fd96b0966d83df598b,
title = "Autophagy as a therapeutic target in cardiovascular disease",
abstract = "The epidemic of heart failure continues apace, and development of novel therapies with clinical efficacy has lagged. Now, important insights into the molecular circuitry of cardiovascular autophagy have raised the prospect that this cellular pathway of protein quality control may be a target of clinical relevance. Whereas basal levels of autophagy are required for cell survival, excessive levels - or perhaps distinct forms of autophagic flux - contribute to disease pathogenesis. Our challenge will be to distinguish mechanisms that drive adaptive versus maladaptive autophagy and to manipulate those pathways for therapeutic gain. Recent evidence suggests this may be possible. Here, we review the fundamental biology of autophagy and its role in a variety of forms of cardiovascular disease. We discuss ways in which this evolutionarily conserved catabolic mechanism can be manipulated, discuss studies presently underway in heart disease, and provide our perspective on where this exciting field may lead in the future. This article is part of a special issue entitled {"}Key Signaling Molecules in Hypertrophy and Heart Failure.{"}",
keywords = "AMPK, Autophagy, Cardiac hypertrophy, HDAC inhibitors, Heart failure, Hypertrophy, IP3, MTOR, P53, PKA, Plasticity, Remodeling",
author = "Andriy Nemchenko and Mario Chiong and Turer, {Aslan T} and Sergio Lavandero and Hill, {Joseph A}",
year = "2011",
month = "10",
doi = "10.1016/j.yjmcc.2011.06.010",
language = "English (US)",
volume = "51",
pages = "584--593",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Autophagy as a therapeutic target in cardiovascular disease

AU - Nemchenko, Andriy

AU - Chiong, Mario

AU - Turer, Aslan T

AU - Lavandero, Sergio

AU - Hill, Joseph A

PY - 2011/10

Y1 - 2011/10

N2 - The epidemic of heart failure continues apace, and development of novel therapies with clinical efficacy has lagged. Now, important insights into the molecular circuitry of cardiovascular autophagy have raised the prospect that this cellular pathway of protein quality control may be a target of clinical relevance. Whereas basal levels of autophagy are required for cell survival, excessive levels - or perhaps distinct forms of autophagic flux - contribute to disease pathogenesis. Our challenge will be to distinguish mechanisms that drive adaptive versus maladaptive autophagy and to manipulate those pathways for therapeutic gain. Recent evidence suggests this may be possible. Here, we review the fundamental biology of autophagy and its role in a variety of forms of cardiovascular disease. We discuss ways in which this evolutionarily conserved catabolic mechanism can be manipulated, discuss studies presently underway in heart disease, and provide our perspective on where this exciting field may lead in the future. This article is part of a special issue entitled "Key Signaling Molecules in Hypertrophy and Heart Failure."

AB - The epidemic of heart failure continues apace, and development of novel therapies with clinical efficacy has lagged. Now, important insights into the molecular circuitry of cardiovascular autophagy have raised the prospect that this cellular pathway of protein quality control may be a target of clinical relevance. Whereas basal levels of autophagy are required for cell survival, excessive levels - or perhaps distinct forms of autophagic flux - contribute to disease pathogenesis. Our challenge will be to distinguish mechanisms that drive adaptive versus maladaptive autophagy and to manipulate those pathways for therapeutic gain. Recent evidence suggests this may be possible. Here, we review the fundamental biology of autophagy and its role in a variety of forms of cardiovascular disease. We discuss ways in which this evolutionarily conserved catabolic mechanism can be manipulated, discuss studies presently underway in heart disease, and provide our perspective on where this exciting field may lead in the future. This article is part of a special issue entitled "Key Signaling Molecules in Hypertrophy and Heart Failure."

KW - AMPK

KW - Autophagy

KW - Cardiac hypertrophy

KW - HDAC inhibitors

KW - Heart failure

KW - Hypertrophy

KW - IP3

KW - MTOR

KW - P53

KW - PKA

KW - Plasticity

KW - Remodeling

UR - http://www.scopus.com/inward/record.url?scp=80052801111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052801111&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2011.06.010

DO - 10.1016/j.yjmcc.2011.06.010

M3 - Article

VL - 51

SP - 584

EP - 593

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 4

ER -